Federated Hermes’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Federated Hermes's NRIX Position: Q3 2026 in Review
Federated Hermes opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 186 shares worth $4.41K. The stake represents ﹤0.01% of the portfolio and ranks #1924 among its holdings. This is a return to the name: Federated Hermes previously reported a position in NRIX as recently as Q1 2025.
Federated Hermes first reported a position in NRIX in Q3 2024 and has held it in 4 quarters since. The position peaked at $948K in Q3 2024. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Federated Hermes held 186 shares of Nurix Therapeutics worth $4.41K as of Q3 2026.
- Nurix Therapeutics was a new Federated Hermes position in Q3 2026.
- Nurix Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1924 holding.
- Federated Hermes first reported a position in Nurix Therapeutics in Q3 2024 and has held it in 4 quarters since.
- Federated Hermes's Nurix Therapeutics position peaked at $948K in Q3 2024.
- 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.